Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Which Sectors Lead Indices During Earnings Season examines which sectors typically drive index gains or losses, guiding allocation decisions.
26,374 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Stocks drift with a quiet S&P 500 backdrop while volatility concentrates in single stocks. The market faces asymmetri...
Two Maverick Capital co-CIOs warn of an air pocket between AI infrastructure and productivity, signaling a market tur...
When a high-profile show nears its end, it’s more than a headline moment—it’s a personal-finance blueprint. This arti...
A niche tech stock tied to crypto and forecasting markets surged today, driven by fresh funding and upbeat sentiment ...
Headline rent figures hide true costs faced by tenants. This piece explains why the 'average rent' mirage misleads, a...
Rising costs and higher rates are pressuring traditional bonds. More retirees replacing bond allocations with dividen...
A budget standoff at U.S. airports can ripple into your wallet long after you land. This article breaks down what hap...
Broadcom has sprinted 23% year to date, but past performance isn’t a guarantee. This guide breaks down the forces beh...
A Wayfair founder sold shares worth about $2.1 million in February 2026. This article breaks down what insider sellin...
A major tech firm is aggressively buying back shares while insiders pile in. This article breaks down what it signals...
When bond yields spiking higher, stock prices can face pressure, especially for growth-focused names. This guide brea...